Clinical Trial Update: A Study of ZT002 Injection With Subjects With Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 study of ZT002 injections in overweight or obese participants has completed. The update does not include results or safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ZT002

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED